Recap: Openlane Q4 Earnings

Openlane (NYSE:KAR) reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:15 PM. Here’s what investors…

byBenzinga Insights

February 20, 2024

1 minute read

Openlane (NYSE:KAR) reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:15 PM.

Here’s what investors need to know about the announcement.

Earnings

Openlane beat estimated earnings by 23.08%, reporting an EPS of $0.16 versus an estimate of $0.13.

Revenue was up $18.50 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 4.35% increase in the share price the next day.

Here’s a look at Openlane’s past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	0.15	0.12	0.09	0.17
EPS Actual	0.18	0.25	0.12	0.33
Revenue Estimate	409.14M	418.82M	393.10M	379.27M
Revenue Actual	416.30M	416.90M	420.60M	372.80M

To track all earnings releases for Openlane visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Bill Holdings Q2 Earnings: Revenue And EPS Beat, Hikes Outlook And More

By Erica Kollmann

February 8, 6:13 PM

Bill Holdings reported quarterly earnings of 63 cents per share, beating the analyst consensus estimate of 40 cents by 57.5% and representing a 50% increase over earnings of 42 cents per share year-over-year. The company reported quarterly sales of $318.5 million which beat the analyst consensus estimate of $298.14 million by 6.83% and is a 22.5% increase over sales of $260.01 million from the same period last year.

BILL

Lifecore Biomedical Provides Update For Development Portfolio And Timing Of Delayed Filings; Anticipates Reporting Its FY24 Q1 Results In Late October Or Early November, Pending Completion Of Its Annual Audit

By Benzinga Newsdesk

October 10, 4:21 PM

Lifecore Biomedical, Inc. ("Lifecore" or the "Company"), a fully integrated contract development and manufacturing organization ("CDMO"), today provided an update on its delayed filings. The Company anticipates reporting

LFCR